The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global IGY Polyclonal Antibodies Market Research Report 2024

Global IGY Polyclonal Antibodies Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1409612

No of Pages : 83

Synopsis
Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
The scientific community has long known that IgY has the proven ability to modulate immune systems. The G.I. tract is the typical entry point for foreign pathogens. By removing pathogens IgY can alleviate stress on the overall system thereby optimizing the body’s natural defense systems. When consumed orally or topically, IgY can identify and attack foreign pathogens that enter via the gut. Antibodies work on both viral and bacterial infections possibly reducing the need for antibiotics.
IgY antibodies have been studied extensively by many government, university and private industry research groups over the years, all concluding the efficacy of IgY in improving overall health. IgY has been used safely in nutraceuticals and vitamins for many years.
The global IGY Polyclonal Antibodies market was valued at US$ 7 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.
The classification of IGY Polyclonal Antibodies includes Primary Antibody and Secondary Antibody. The proportion of Primary Antibody is about 70%, and the proportion of Secondary Antibody is about 30%.
IGY Polyclonal Antibodies are application in Academic Research and Commercial. The most of IGY Polyclonal Antibodies is used in Commercial, and the market share of that is about 60%.
North America is the largest consumption place, with a consumption market share nearly 37%, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is not intense. Merck, IGY Life Sciences, Abcam, Genway Biotech, Good Biotech etc. are the leaders of the industry with the market share are about 66%.
This report aims to provide a comprehensive presentation of the global market for IGY Polyclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IGY Polyclonal Antibodies.
Report Scope
The IGY Polyclonal Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IGY Polyclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IGY Polyclonal Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Capra Science
YO Proteins
GeneTex
Segment by Type
Primary Antibody
Secondary Antibody
Segment by Application
Academic Research
Commercial
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IGY Polyclonal Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IGY Polyclonal Antibodies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Primary Antibody
1.2.3 Secondary Antibody
1.3 Market by Application
1.3.1 Global IGY Polyclonal Antibodies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic Research
1.3.3 Commercial
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IGY Polyclonal Antibodies Market Perspective (2019-2030)
2.2 IGY Polyclonal Antibodies Growth Trends by Region
2.2.1 Global IGY Polyclonal Antibodies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IGY Polyclonal Antibodies Historic Market Size by Region (2019-2024)
2.2.3 IGY Polyclonal Antibodies Forecasted Market Size by Region (2025-2030)
2.3 IGY Polyclonal Antibodies Market Dynamics
2.3.1 IGY Polyclonal Antibodies Industry Trends
2.3.2 IGY Polyclonal Antibodies Market Drivers
2.3.3 IGY Polyclonal Antibodies Market Challenges
2.3.4 IGY Polyclonal Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IGY Polyclonal Antibodies Players by Revenue
3.1.1 Global Top IGY Polyclonal Antibodies Players by Revenue (2019-2024)
3.1.2 Global IGY Polyclonal Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global IGY Polyclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IGY Polyclonal Antibodies Revenue
3.4 Global IGY Polyclonal Antibodies Market Concentration Ratio
3.4.1 Global IGY Polyclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IGY Polyclonal Antibodies Revenue in 2023
3.5 IGY Polyclonal Antibodies Key Players Head office and Area Served
3.6 Key Players IGY Polyclonal Antibodies Product Solution and Service
3.7 Date of Enter into IGY Polyclonal Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IGY Polyclonal Antibodies Breakdown Data by Type
4.1 Global IGY Polyclonal Antibodies Historic Market Size by Type (2019-2024)
4.2 Global IGY Polyclonal Antibodies Forecasted Market Size by Type (2025-2030)
5 IGY Polyclonal Antibodies Breakdown Data by Application
5.1 Global IGY Polyclonal Antibodies Historic Market Size by Application (2019-2024)
5.2 Global IGY Polyclonal Antibodies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IGY Polyclonal Antibodies Market Size (2019-2030)
6.2 North America IGY Polyclonal Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IGY Polyclonal Antibodies Market Size by Country (2019-2024)
6.4 North America IGY Polyclonal Antibodies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IGY Polyclonal Antibodies Market Size (2019-2030)
7.2 Europe IGY Polyclonal Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IGY Polyclonal Antibodies Market Size by Country (2019-2024)
7.4 Europe IGY Polyclonal Antibodies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IGY Polyclonal Antibodies Market Size (2019-2030)
8.2 Asia-Pacific IGY Polyclonal Antibodies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IGY Polyclonal Antibodies Market Size by Region (2019-2024)
8.4 Asia-Pacific IGY Polyclonal Antibodies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IGY Polyclonal Antibodies Market Size (2019-2030)
9.2 Latin America IGY Polyclonal Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IGY Polyclonal Antibodies Market Size by Country (2019-2024)
9.4 Latin America IGY Polyclonal Antibodies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IGY Polyclonal Antibodies Market Size (2019-2030)
10.2 Middle East & Africa IGY Polyclonal Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IGY Polyclonal Antibodies Market Size by Country (2019-2024)
10.4 Middle East & Africa IGY Polyclonal Antibodies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck IGY Polyclonal Antibodies Introduction
11.1.4 Merck Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.1.5 Merck Recent Development
11.2 IGY Life Sciences
11.2.1 IGY Life Sciences Company Detail
11.2.2 IGY Life Sciences Business Overview
11.2.3 IGY Life Sciences IGY Polyclonal Antibodies Introduction
11.2.4 IGY Life Sciences Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.2.5 IGY Life Sciences Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam IGY Polyclonal Antibodies Introduction
11.3.4 Abcam Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Genway Biotech
11.4.1 Genway Biotech Company Detail
11.4.2 Genway Biotech Business Overview
11.4.3 Genway Biotech IGY Polyclonal Antibodies Introduction
11.4.4 Genway Biotech Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.4.5 Genway Biotech Recent Development
11.5 Good Biotech
11.5.1 Good Biotech Company Detail
11.5.2 Good Biotech Business Overview
11.5.3 Good Biotech IGY Polyclonal Antibodies Introduction
11.5.4 Good Biotech Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.5.5 Good Biotech Recent Development
11.6 Gallus Immunotech
11.6.1 Gallus Immunotech Company Detail
11.6.2 Gallus Immunotech Business Overview
11.6.3 Gallus Immunotech IGY Polyclonal Antibodies Introduction
11.6.4 Gallus Immunotech Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.6.5 Gallus Immunotech Recent Development
11.7 Creative Diagnostics
11.7.1 Creative Diagnostics Company Detail
11.7.2 Creative Diagnostics Business Overview
11.7.3 Creative Diagnostics IGY Polyclonal Antibodies Introduction
11.7.4 Creative Diagnostics Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.7.5 Creative Diagnostics Recent Development
11.8 Agrisera
11.8.1 Agrisera Company Detail
11.8.2 Agrisera Business Overview
11.8.3 Agrisera IGY Polyclonal Antibodies Introduction
11.8.4 Agrisera Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.8.5 Agrisera Recent Development
11.9 Innovagen AB
11.9.1 Innovagen AB Company Detail
11.9.2 Innovagen AB Business Overview
11.9.3 Innovagen AB IGY Polyclonal Antibodies Introduction
11.9.4 Innovagen AB Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.9.5 Innovagen AB Recent Development
11.10 Capra Science
11.10.1 Capra Science Company Detail
11.10.2 Capra Science Business Overview
11.10.3 Capra Science IGY Polyclonal Antibodies Introduction
11.10.4 Capra Science Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.10.5 Capra Science Recent Development
11.11 YO Proteins
11.11.1 YO Proteins Company Detail
11.11.2 YO Proteins Business Overview
11.11.3 YO Proteins IGY Polyclonal Antibodies Introduction
11.11.4 YO Proteins Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.11.5 YO Proteins Recent Development
11.12 GeneTex
11.12.1 GeneTex Company Detail
11.12.2 GeneTex Business Overview
11.12.3 GeneTex IGY Polyclonal Antibodies Introduction
11.12.4 GeneTex Revenue in IGY Polyclonal Antibodies Business (2019-2024)
11.12.5 GeneTex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’